Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer.
Jett, J R
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 1994 - 2321-6 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
0732-183X
10.1200/JCO.1994.12.11.2321 doi
Adult
Aged
Blood Platelet Disorders--etiology
Carcinoma, Small Cell--mortality
Combined Modality Therapy
Dose-Response Relationship, Drug
Female
Humans
Interferon-gamma--adverse effects
Lung Neoplasms--mortality
Male
Middle Aged
Multivariate Analysis
Patient Compliance
Platelet Count
Recombinant Proteins
Remission Induction
Survival Analysis
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 1994 - 2321-6 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
0732-183X
10.1200/JCO.1994.12.11.2321 doi
Adult
Aged
Blood Platelet Disorders--etiology
Carcinoma, Small Cell--mortality
Combined Modality Therapy
Dose-Response Relationship, Drug
Female
Humans
Interferon-gamma--adverse effects
Lung Neoplasms--mortality
Male
Middle Aged
Multivariate Analysis
Patient Compliance
Platelet Count
Recombinant Proteins
Remission Induction
Survival Analysis